[Recalled] QUCARE Total Cholesterol in vitro diagnostic test REF: 6407 — The devices were distributed without required FDA premarket clearance or approv… | FDA 2026-04-02
The product on this page is subject to an official recall. We summarise the regulator's findings and the recommended action.
Recall details
| Product | QUCARE Total Cholesterol in vitro diagnostic test REF: 6407 |
|---|---|
| Brand / manufacturer | DFI Co., Ltd. |
| Category | device |
| Issuing authority | FDA_DEVICE |
| Reference | Z-2085-2026 |
| Country of notice | Korea (the Republic of) |
| Risk level | Class II |
| Hazard type | recall |
| Notice date | 02 April 2026 |
| EAN / barcode | 08806141303060 |
Why it was recalled
According to the FDA_DEVICE notice, the identified hazard is: The devices were distributed without required FDA premarket clearance or approval.
This Class II recall concerns device products distributed in Korea (the Republic of) and was recorded by FDA_DEVICE. Recalls in this category are published so that owners, retailers, and importers can identify affected units and act quickly.
What to do if you own this product
Check whether your unit is affected and follow the authority's guidance before further use.
Read the full official notice →
Related recalls from DFI Co., Ltd.
This page indexes a public government recall notice for reference. We do not sell or verify this product; always confirm the current status on the authority's official site.
- Best Fiction, Mystery & Detective Books for Vegans
- Top Organic Seasoning Mixes, Salts, Marinades & Tenderizers for Flavor and Health
- The Healthiest Candy Options: Sweet Treats Without the Guilt
- Cheapest Vitamins and Supplements Online – Where to Buy Without Breaking the Bank
- Top Rated Frozen Fish & Seafood Brands: A Buyer's Guide
- What is 1,3-propanesultone (CAS 1120-71-4)? Safety, Regulation & EU/US/Canada Perspective | ProductGuru